Life Tech Sues Bio-Rad for Infringing Protein-Production Patents | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies has filed suit against Bio-Rad for allegedly infringing four patents that cover methods for protein production, according to court documents filed last week.

Life Technologies filed a complaint on Aug. 13 in the US District Court for the District of Delaware charging Bio-Rad with infringing four patents: US Patent Nos. 6,703,484; 7,223,566; 7,259,242; and 7,265,206. All four patents describe methods for producing polypeptides in bacterial host cells and are assigned to Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."